Aldeide laurica, min 98%, per sintesi, 50 ml, confezione in vetro

2,2,3,3-Tetrafluoro-2,3-dihydro-1,4-benzodioxine, 98%, 1g

(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime, 95+%, 25mg

1-Methyl-4-nitro-2-phenylbenzene, 95+%, 1g

Methyl 2-bromo-6-methoxynicotinate, 95.0%, 1g

Acido indol-3-acetico, minimo 99%, per biochimica, 50 g, confezione in plastica.

2,2-DIMETHYL-3,4-DIHYDRO-2H-BENZO[B][1,4]THIAZINE, 97.0%, 250mg

Condensatore di Abbe 1,25 NA con apertura per campo scuro e vetrino per contrasto di fase. Senza vetrino per campo scuro e senza vetrini per contrasto di fase

3-Amino-5-phenyl-thiophene-2-carboxylic acid ethyl ester, 95.0%, 5g

n-((Benzyloxy)carbonyl)-N-(2,2,2-trifluoroethyl)glycine, 95%, 100mg

Substance P (9-11), 99.0%, 250mg

1-tert-Butyl 2-methyl (2S)-2-methylpyrrolidine-1,2-dicarboxylate, 95%, 1g

Methyl 5-hydroxymethyl-1-methyl-1H-pyrazole-3-carboxylate, 95.0%, 25g